“…The mean number of patients across all studies was 50 (range: 2-220). There were 887 TR (84 %), and 165 PR (16%) with 6 studies (382 patients) combining TR (259 patients) and PR (123 patients) [ 9,29,32,34,38,40], 11 studies with solely TR (628 patients: 335 cryopreserved allografts, 259 autogenous veins, 23 standard polyesters/ PTFE, and 11 rifampicin-bonded polyesters) [7,8,10,28,30,31,33,35,39,41,42] and 4 studies with solely PR (42 patients: 23 autogenous veins, 11 silver-coated polyesters, and 8 standard polyesters/PTFE) [17,18,36,37].…”